Pharmanutra PR | Publication of the Lists Submitted for the Appointment of the Stock: price and insider trades · Italy
Pharmanutra PR | Publication of the Lists Submitted for the Appointment of the: what insiders have been doing
We have very little insider data for Pharmanutra PR | Publication of the Lists Submitted for the Appointment of the so far: the most recent filing dates from 6 April 2026. With so few records, no pattern can be drawn yet. Source: insider filings from Consob. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 8,100 of 26,911 companies
61.5
score / 100
Value38
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€83.20
Analyst consensus
3 analysts€76.00Target €81.33(-2%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.8x
PER (forward)27.2x
P/Book10.7x
Beta0.19
Balance sheet & cash
Market cap€796.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions16.7%
Last declaration on 6 April 2026
Declarations1 total
- ●Executives0Consob
1 of 1 declaration
About Pharmanutra PR | Publication of the Lists Submitted for the Appointment of the
Pharmanutra PR is a company focused on publishing lists submitted for appointments in the health and pharmaceutical sector. It operates in the XMIL market.
